COLL
Collegium Pharmaceutical, Inc.
COLL trails on the overall score without a compensating advantage in the available component scores.
UNH
UnitedHealth Group Incorporated
UNH has the edge over COLL overall, supported by stronger modeled upside and stronger valuation.
COLL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Strong |
COLL's cash flow and balance sheet are currently strong, and its revenue and profitability are stable.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
COLL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.5x | $24.95 | — |
| Cheap | 13x | $12.57 | -50% |
| Fair | 19x | $19.08 | -24% |
| Current | 25x | $24.95 | — |
| Expensive | 34x | $33.57 | +35% |
Historical ranges are pointers, not guarantees.
COLL's PE is in its expensive range at 25x. On analysts' estimates for next year's earnings, today's price would be 3.5x, in its cheap range.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH has the edge over COLL in the historical PE scenario, which offers more potential upside but is not a forecast.
COLL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect COLL's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
COLL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.07 | +607% |
| Q3 2026 | $1.00 | -38% |
| Q2 2026 | $1.24 | +19% |
| Q1 2026 | $2.04 | +67% |
| Q4 2025 | $1.71 | -8.1% |
| Q3 2025 | $1.61 | -31% |
| Q2 2025 | $1.04 | -60% |
| Q1 2025 | $1.22 | -49% |
| Q4 2024 | $1.86 | +58% |
COLL's earnings per share have fallen from their peak: $1.00 over the past year, against $2.72 in mid-2021.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over COLL on earnings, with stronger typical year-over-year growth.
COLL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $216.3M | +3.3% |
| Q2 2026 | $199.9M | +6.3% |
| Q1 2026 | $193.5M | +8.9% |
| Q4 2025 | $205.4M | +13% |
| Q3 2025 | $209.4M | +31% |
| Q2 2025 | $188M | +29% |
| Q1 2025 | $177.8M | +23% |
| Q4 2024 | $181.9M | +22% |
COLL has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | -16 points |
| Q2 2026 | 1.9% | -17 points |
| Q1 2026 | 16% | +3.8 points |
| Q4 2025 | 30% | +8.6 points |
| Q3 2025 | 30% | +7.8 points |
| Q2 2025 | 19% | -14 points |
| Q1 2025 | 12% | -22 points |
| Q4 2024 | 21% | -20 points |
COLL has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
COLL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $86.3M | +10% |
| Q2 2026 | $70.8M | -2.1% |
| Q1 2026 | $56.8M | +4.1% |
| Q4 2025 | $122.4M | +46% |
| Q3 2025 | $78.3M | +$87.5M |
| Q2 2025 | $72.4M | +7.8% |
| Q1 2025 | $54.6M | -11% |
| Q4 2024 | $84.1M | +15% |
COLL has the edge over UNH on cash flow, with more consistent year-over-year improvement.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
COLL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +20% | +6.7M shares |
| 1 year | -0.8% | -329K shares |
| 3 years | -7% | -2.9M shares |
| 5 years | +7.9% | +2.8M shares |
| Available history | +16% | +5.5M shares |
COLL has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2024 | $25M |
| Q3 2024 | — |
| Q4 2023 | $25M |
| Q4 2022 | $7.6M |
| Q4 2021 | $32.3M |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
COLL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.3x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.0x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.6x | Very low |
COLL has the edge over UNH on leverage, with a lower net debt burden relative to earnings.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
COLL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.8 | Neutral |
| Stochastic | 25.6 | Neutral |
COLL's weekly RSI is 39 (neutral) and its Stochastic is 26 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
COLL PE vs Healthcare Sector
| Metric | COLL | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 26x | 3.5% below |
| PE % | 66 | 29 | 37 pts above |
COLL is trading at 25x earnings, in line with the Healthcare sector's median of 26x.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over COLL on valuation relative to its sector.
COLL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.2 | 7.5% above |
| 20 week MA | $27.2 | 8.2% below |
| 50 week MA | $34.7 | 28% below |
| 100 week MA | $33.7 | 26% below |
| 200 week MA | $31.6 | 21% below |
COLL has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 21% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over COLL on trend strength, trading above more of its moving averages.
COLL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.0 | $18.6 | -12% |
| 2021 | $18.6 | $19.5 | +4.9% |
| 2022 | $19.5 | $23.0 | +18% |
| 2023 | $23.0 | $30.8 | +34% |
| 2024 | $30.8 | $29.1 | -5.4% |
| 2025 | $29.1 | $49.8 | +71% |
| 2026 YTD | $49.8 | $25.0 | -50% |
COLL is down 50% so far in 2026, after finishing higher in four of the previous six years.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over COLL on returns for 2026, with the stronger performance.